Dr. Kate Hillier Rejoins Latham & Watkins, Enhancing Life Sciences Expertise in Bay Area
Latham & Watkins LLP has announced the return of Dr. Kate Hillier to its Bay Area offices as a partner in the Healthcare & Life Sciences Practice. Dr. Hillier, who has significant expertise in strategic intellectual property (IP) counseling and licensing, along with collaboration transactions in the life sciences sector, is set to play a vital role in advancing the firm's services for public and private life sciences firms.
The rejoining of Dr. Hillier is celebrated by Mark Bekheit, the Office Managing Partner at Latham's Bay Area offices. He expressed enthusiasm about her return, emphasizing that her in-depth understanding of licensing and collaboration transactions will be instrumental to Latham's growing Emerging Companies & Growth Practice. Her presence is also expected to enhance the firm’s corporate, mergers and acquisitions (M&A), and regulatory offerings, especially where they intersect with the life sciences and healthcare sectors.
Dr. Hillier’s career is marked by substantial academic and clinical experience, which she employs to maximize the value of the products and technologies of her clients. She regularly advises companies on strategic IP licensing, collaboration agreements, and complex commercial transactions that include foundational in-licenses. Her adeptness at structuring and negotiating critical agreements showcases her ability to navigate the complexities of the life sciences industry.
John Manthei, the Global Chair of Latham's Healthcare & Life Sciences Practice, highlighted that Dr. Hillier’s expertise aligns perfectly with the increasing demands of their clients. He pointed out that her abilities in strategic partnering and navigation through intricate transactions bolster Latham's position as a leading destination for healthcare and life sciences companies, as well as the legal talent servicing these entities.
Dr. Hillier expressed her excitement about returning to Latham, reflecting on the firm’s robust global platform and depth of expertise across private equity, biotechnology, and healthcare. She noted that the collaborative environment at Latham provides an ideal foundation for delivering exceptional services to clients.
Before her rejoining, Dr. Hillier served at Cooley, bringing with her a wealth of international credentials. She earned her JD from the University of Cambridge (Jesus College) and a Diploma in Legal Practice from the Oxford Institute of Legal Practice. Notably, she is also a qualified anesthesiologist with prior experience in the UK and Australia.
The return of Dr. Hillier not only showcases Latham's commitment to attracting top legal talent but also reinforces its role in supporting life sciences companies through experienced legal counsel. As the healthcare landscape evolves with new challenges and opportunities, having seasoned professionals like Dr. Hillier is crucial for the firm and its clients.
As Latham & Watkins continues to expand its footprint in the Healthcare and Life Sciences sectors, the appointment of Dr. Hillier signals a strong commitment to providing the highest level of legal services and strategic support in this competitive industry. Her extensive background and experience are expected to be significant assets as Latham aims to enhance its position in the market and provide unparalleled service to clients navigating the complexities of life sciences transactions.
The rejoining of Dr. Hillier is celebrated by Mark Bekheit, the Office Managing Partner at Latham's Bay Area offices. He expressed enthusiasm about her return, emphasizing that her in-depth understanding of licensing and collaboration transactions will be instrumental to Latham's growing Emerging Companies & Growth Practice. Her presence is also expected to enhance the firm’s corporate, mergers and acquisitions (M&A), and regulatory offerings, especially where they intersect with the life sciences and healthcare sectors.
Dr. Hillier’s career is marked by substantial academic and clinical experience, which she employs to maximize the value of the products and technologies of her clients. She regularly advises companies on strategic IP licensing, collaboration agreements, and complex commercial transactions that include foundational in-licenses. Her adeptness at structuring and negotiating critical agreements showcases her ability to navigate the complexities of the life sciences industry.
John Manthei, the Global Chair of Latham's Healthcare & Life Sciences Practice, highlighted that Dr. Hillier’s expertise aligns perfectly with the increasing demands of their clients. He pointed out that her abilities in strategic partnering and navigation through intricate transactions bolster Latham's position as a leading destination for healthcare and life sciences companies, as well as the legal talent servicing these entities.
Dr. Hillier expressed her excitement about returning to Latham, reflecting on the firm’s robust global platform and depth of expertise across private equity, biotechnology, and healthcare. She noted that the collaborative environment at Latham provides an ideal foundation for delivering exceptional services to clients.
Before her rejoining, Dr. Hillier served at Cooley, bringing with her a wealth of international credentials. She earned her JD from the University of Cambridge (Jesus College) and a Diploma in Legal Practice from the Oxford Institute of Legal Practice. Notably, she is also a qualified anesthesiologist with prior experience in the UK and Australia.
The return of Dr. Hillier not only showcases Latham's commitment to attracting top legal talent but also reinforces its role in supporting life sciences companies through experienced legal counsel. As the healthcare landscape evolves with new challenges and opportunities, having seasoned professionals like Dr. Hillier is crucial for the firm and its clients.
As Latham & Watkins continues to expand its footprint in the Healthcare and Life Sciences sectors, the appointment of Dr. Hillier signals a strong commitment to providing the highest level of legal services and strategic support in this competitive industry. Her extensive background and experience are expected to be significant assets as Latham aims to enhance its position in the market and provide unparalleled service to clients navigating the complexities of life sciences transactions.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.